VALPOSAFE 300CR

COMPOSITION - Sodium Valproate 200 mg + Valproic Acid 87 mg (Controlled Release) Tablets

DESCRIPTION - VALPOSAFE 300 CR is a controlled-release anticonvulsant formulation. Sodium valproate and valproic acid increase gamma-aminobutyric acid (GABA) levels in the brain, enhancing inhibitory neurotransmission and stabilizing neuronal activity. This reduces abnormal electrical discharges responsible for seizures. The controlled-release formulation provides sustained plasma levels for improved seizure control and better patient compliance.

Uses 

• Epilepsy
• Generalized seizures
• Partial seizures
• Neurological seizure disorders
• Bipolar disorder (as mood stabilizer)

Side Effects

• Nausea
• Weight gain
• Tremors
• Drowsiness
• Hair loss (temporary)

Precautions / Other Important Details 

• Monitor liver function during therapy
• Use cautiously in patients with liver disease
• Avoid abrupt discontinuation
• Not recommended during pregnancy (risk of fetal harm)
• Regular monitoring of blood levels may be required